Pressure BioSciences, Inc. (PBIO) Corporate Media Kit

COMPANY OVERVIEW (OTCQB: PBIO) Three Business Segments - Three Unique Technology Platforms 3 ➢ Research Products and Services ( PCT Platform ) • PCT: Pressure Cycling Technology (alternating cycles of high/low pressure to control biomolecules) • Focus: to streamline and improve the characterization and quality control of protein therapeutics for the Biopharma market. Also offers an effective means of rapid, consistent, and reliable sample preparation for biomarker and target discovery and clinical diagnostics and research laboratories. • 15 Patents, 325 PCT Systems installed, 200+ customers, 120+ publications, FY2018 revenue ($2.4M) ➢ Biopharma Contract Services ( BaroFold Platform ) • BaroFold: Pressure Enabled Disaggregation and Controlled Refolding of Proteins • Focus: to improve the quality of protein therapeutics, accelerate therapeutic protein development, and manufacture follow-on biologics by employing high pressure for disaggregation & controlled refolding of recombinant proteins into their native structures for desired drug activity. • 8 Patents, Dec 2017 BaroFold Inc. Acquisition, Commercial Launch of BCS Business on Jan 7, 2019 ➢ Nanoemulsion Manufacturing Services ( UST Platform ) • UST: Ultra Shear Technology (uniquely combines high hydrostatic pressure & intense shear forces) • Focus: to produce higher quality, more stable nanoemulsions with improved absorption, higher bioavailability, and lower surfactant levels: results in better quality food, pharmaceuticals, nutraceuticals, cosmetics, and cannabis oil extracts (water soluble CBD) compared to standard emulsions • 2 Patents, Commercial Launch of BaroShear K45 in July 2019